Profile
Currently, James P. Bilotta occupies the position of Chief Information Officer & SVP at Alnylam Pharmaceuticals, Inc. He previously was Senior Manager-Information Technology at Purdue Pharma LP and Chief Information Officer & Vice President at Alexion Pharmaceuticals, Inc. James P. Bilotta received an MBA and an undergraduate degree from Southern Connecticut State University.
James Bilotta active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/07/2024 |
Former positions of James Bilotta
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/07/2024 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2013 |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Chief Tech/Sci/R&D Officer | 31/03/2004 |
Training of James Bilotta
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Southern Connecticut State University
Southern Connecticut State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
- Stock Market
- Insiders
- James Bilotta
















